years in the International market
Medicine Access with SPL Pharma
Pharmaceutical access programs are being implemented by an increasing number of pharmaceutical companies.
Our group have commercial operations within the UK, USA and Brazil working directly with manufacturers to enable physicians and patients access to the latest treatments on the market prior to the commercial local launch of the medication.
We have the experience and knowledge to ensure the correct documentation and transparency is provided to the manufacturer whilst also ensuring all pharmaceutical products supplied comply with local regulations.
EAP - Early Access Programmes
MAP - Managed Access Programmes
GAP - Global Access Programmes
To find our more about how SPL Pharma work directly with manufacturers on the above access programmes please contact us.
Pharmaceutical company that handles managed access programmes | Pharmaceutical company that handles EAP | Pharmaceutical company that handles Early access programmes | Pharmaceutical company that handles Managed Access programmes | Pharmaceutical company that handles unlicenced medicine | Early access programmes for Brazil | Company that can supply pharmaceuticals to Latin America | International Pharmaceutical access programmes |